Remove 2014 Remove Fraud Remove Licensing Remove Public Health
article thumbnail

Preventing Unlicensed Individuals and Subsequent Fraudulent Claims Submission

Provider Trust

On June 7, 2022, Theresa Pickering of Norcross, Georgia was indicted by a federal grand jury on federal charges of health care fraud, aggravated identity theft, and distribution of controlled substances. In addition to these allegations of fraud, waste, and abuse, Pickering had a history of fraud. According to the U.S.

article thumbnail

Two NY Home Healthcare Agencies Settle False Claims Act Allegations for $5.4 Million 

Healthcare Compliance Blog

The New York Wage Parity Act, Public Health Law sets minimum wage and benefit requirements for licensed home care services agencies (LHCSAs) that employ home care aides who render services to Medicaid recipients in New York City and three counties in New York. million to New York State for conduct between 2014–2017.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMS Issues Contract Year 2023 Final Rule for Medicare Advantage Organizations and Prescription Drug Sponsors

Healthcare Law Blog

Allow CMS to Calculate Star Ratings for Certain Measures for 2023 Given Impacts of the COVID-19 Public Health Emergency (§ 422.166). ii) disclose to the beneficiary that he or she is being transferred to a licensed agent who can enroll him or her into a new plan.

article thumbnail

Health Provider News – April 1, 2022

Hall Render

Coalition of hospitals, health plans and others urge for stronger guidance around third-party apps. Hospital, long-term care groups again petition Becerra to extend COVID-19 public health emergency. Rural Alabama wastewater infrastructure ‘public health issue’ gets much-needed attention.

article thumbnail

The 2021 Shkreli Awards: Lown Institute Counts Down the Top 10 Healthcare Industry Abuses in the Coronavirus Pandemic

Health Populi

When he led Turing Pharmaceuticals in 2015, he acquired a license for the drug Daraprim (an anti-malarial therapy also used for HIV/AIDS), raising the drug price from $13.50 Shkreli was ultimately convicted on securities fraud (not related to the Draprim pricing strategy). a pill to $750 a pill.